167 results on '"Ficker, Joachim H."'
Search Results
2. Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study
3. Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
4. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
5. CAT score single item analysis in patients with COPD: Results from COSYCONET
6. Positive airway pressure telehealth models and long-term therapy termination: a healthcare database analysis.
7. Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD
8. Effect of a patient engagement tool on positive airway pressure adherence: analysis of a German healthcare provider database
9. Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
10. Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium
11. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
12. Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report.
13. German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM)
14. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial
15. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
16. Predictors of positive airway pressure therapy termination in the first year: analysis of big data from a German homecare provider
17. Telemedicine-based proactive patient management during positive airway pressure therapy: Impact on therapy termination rate
18. Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
19. Detection of cardiovascular risk from a photoplethysmographic signal using a matching pursuit algorithm
20. Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy.
21. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET
22. Erratum to: German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM)
23. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET.
24. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis.
25. Bridging Whole-Lung Lavage with Venovenous Extracorporeal Life Support for Pulmonary Alveolar Proteinosis
26. Glycopyrronium and Tiotropium Demonstrate Similar Improvements in Lung Function and Reductions in Exacerbations in Severe-To-Very Severe COPD: The SPARK Study: OS215
27. an international multicentre single-arm clinical trial
28. Adherence to Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea: Impact of Patient Education after a Longer Treatment Period
29. Endobronchial Valve (Zephyr) Treatment in Homogeneous Emphysema: One-Year Results from the IMPACT Randomized Clinical Trial.
30. Beyond the AHI–pulse wave analysis during sleep for recognition of cardiovascular risk in sleep apnea patients.
31. Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET.
32. Continuous Positive Airway Pressure Treatment Rapidly Improves Insulin Sensitivity in Patients with Obstructive Sleep Apnea Syndrome
33. Humidification During Continuous Positive Airway Pressure Therapy
34. Afatinib as first-line treatment in patients with EGFR -mutated non-small cell lung cancer in routine clinical practice.
35. Sensitivity of a simplified forced oscillation technique for detection of upper airway obstruction
36. CMR imaging for follow up of isolated cardiac sarcoidosis with extensive biventricular involvement
37. Effects of continuous positive airway pressure therapy on daytime and nighttime arterial blood pressure in patients with severe obstructive sleep apnea and endothelial dysfunction.
38. Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
39. Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort.
40. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
41. Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort.
42. Medical Treatment of COPD: An Analysis of Guideline-Adherent Prescribing in a Large National Cohort (COSYCONET).
43. Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.
44. Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
45. Vascular stiffness determined from a nocturnal digital pulse wave signal: association with sleep, sleep-disordered breathing, and hypertension.
46. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.
47. Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication.
48. Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results
49. Parameters of Overnight Pulse Wave under Treatment in Obstructive Sleep Apnea.
50. The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.